PACE  HEALTH  SYSTEMS  LTD

 

Right First Time  

 

UNIQUE BONE MARROW NEEDLE

    RELIABLE SAMPLE RETRIEVAL

    SIMPLE TO OPERATE

    LOW COST 

    BRAND NEW DESIGN CONCEPT     

   LOOK AT THE CANNULA TIP

MODIFICATIONS TO STANDARD JAMSHIDI:

FOUR PARTIAL THICKNESS SHARPENED GROOVES ABOUT 3 CM LONG  -              CUTS AWAY UNWANTED BONE

TWO FULL THICKNESS SLOTS ABOUT 2MM LONG AT THE VERY TIP -                HELPS  TO CAPTURE THE SPECIMEN

                    

                                                                                                                           top   

VIDEO CLIP DEMONSTRATING OPERATION

this may take a minute or so to load 

You can replay this video clip by right clicking over the image

Essentially the operating method is no different from that using a standard Jamshidi needle.  With our needle however, by TILTING AND ROTATING the needle, after it has been fully inserted, the high precision, sharpened grooves on the external surface of the cannula tip cut away unwanted bone;  the full thickness grooves at the very tip grab the specimen at it's tip and free it from the underlying bone, so when the operator withdraws the needle, the biopsy is captured. 

 

 

SAMPLES ARE 20% BROADER THAN EQUIVALENT JAMSHIDI

This can be achieved because there is less swaging (narrowing) at the tip of our needles compared to the standard Jamshidi.  This is possible as we have a much more efficient way of capturing the sample.

 

SAMPLES ARE EXCELLENT QUALITY

The biopsy sample is protected within the cannula during the whole process - just like in the Jamshidi needle - so there is no possibility to damage the sample.  Unlike some of our competitors' devices, there is no need for additional (expensive) components, which when inserted into the cannula, can snare or damage the biopsy.

 

SUMMARY OF ADVANTAGES

RELIABLE SAMPLE RETRIEVAL

SIMPLE MODIFICATION OF TRUSTED JAMSHIDI DESIGN

NO ADDITIONAL MOVING PARTS

LAGER SAMPLES

HIGH QUALITY SAMPLES

COST EFFECTIVE

 

AVAILABILITY

Expected on the market Sep 2004                        top    

                                                                                              

 

I